Aimee Rodriguez Musso

Aimee Rodriguez Musso

Auto-generated profile, based on publicly available information

Aimee Rodriguez Musso

Department of Cardiovascular Imaging, Heart and Lung Institute, University Hospital of Lille, 59000 Lille, France

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
CGChristos Gkizas
Christos Gkizas
BLBenjamin Longère
Benjamin Longère
OSOlga Sliwicka
Olga Sliwicka
AMAimee Rodriguez Musso
Aimee Rodriguez Musso
GLGilles Lemesle
Gilles Lemesle
FPFRANCOIS PONTANA
FRANCOIS PONTANA

13 September 2025 in Diagnostic and Interventional Imaging
Verified
Journal Article
Open access
CGChristos Gkizas
Christos Gkizas
BLBenjamin Longère
Benjamin Longère
SBSaad Bechrouri
Saad Bechrouri
HRHelene Ridon
Helene Ridon
AMAimee Rodriguez Musso
Aimee Rodriguez Musso
FPFRANCOIS PONTANA
FRANCOIS PONTANA
The purpose of this study was to evaluate the diagnostic performance of myocardial extracellular volume (ECV) quantification using dual-source photon-counting detector computed tomography (PCCT) compared to cardiac magnetic resonance imaging (MRI) for assessing the severity of myocardial fibrosis in patients with hypertrophic cardiomyopathy (HCM). Patients with HCM due to sarcomere mutations underwent cardiac computed tomography angiography (CCTA) using a first-generation PCCT scanner, followed by comprehensive cardiac MRI. The CCTA protocol included a late iodine enhancement acquisition in spectral mode, 5 min after contrast media injection. ECV was calculated from the iodine ratio of the myocardium and blood pool on late iodine enhancement PCCT images. Cardiac MRI biomarkers included T1 mapping, ECV, and late gadolinium enhancement percentage (LGE). Diagnostic capabilities of PCCT were estimated using sensitivity, specificity, accuracy, interobserver agreement for myocardial fibrosis, area under the receiver operating characteristic curve (AUC) analyses for optimal thresholds, and correlations between tissue characteristics, functional capacity, and biomarkers. Thirty patients were retrospectively included. There were 22 men and eight women with a mean age of 59 ± 13.8 (standard deviation [SD]). The mean dose length product of late enhancement PCCT scanning was 105 ± 45 (SD) mGy.cm. No significant differences were found between global PCCT-derived ECV (30.0 ± 4.8 [SD] %) and MRI-derived ECV (30.62 ± 4.2 [SD] %) (P = 0.59). Linear regression revealed a strong segmental correlation between PCCT and MRI (basal, r = 0.89; mid-ventricular, r = 0.85; apical, r = 0.85; P < 0.001). An optimal PCCT-derived ECV threshold of 33.4 % allowed the diagnosis of LGE ≥ 15 % with 80 % sensitivity, 76 % specificity, and an AUC of 0.77, not significantly different from MRI-derived ECV (threshold 33.9 %; sensitivity, 80 %; specificity, 76 %, AUC, 0.80; P = 0.176). PCCT-derived ECV correlated with peak VO₂ (r = -0.76) and NT-proBNP levels (r = 0.59). PCCT-derived ECV shows promise for quantifying myocardial fibrosis in HCM, offering a valuable non-invasive alternative to cardiac MRI, especially for patients with contraindications or those requiring combined CCTA and myocardial assessment.

30 October 2025 in Diagnostic and Interventional Imaging
Verified
Journal Article
Open access
BLBenjamin Longère
Benjamin Longère
HCHippolyte Caseneuve
Hippolyte Caseneuve
CGChristos V Gkizas
Christos V Gkizas
AMAimée Rodriguez Musso
Aimée Rodriguez Musso
MTMariia Tregubova
Mariia Tregubova
FPFRANCOIS PONTANA
FRANCOIS PONTANA
The purpose of this study was to evaluate the feasibility and diagnostic performance of stress myocardial perfusion imaging (MPI) using a first-generation dual-source photon-counting CT (PCCT) scanner by comparison with reference standards. Consecutive patients referred for coronary CT angiography (CCTA) with concomitant stress MPI using PCCT scanner and at least one functional reference test within one month were included. Static PCCT-MPI with regadenoson (Rapiscan, GE Healthcare) was acquired 12 s after the intravenous administration of 40 mL of iodinated contrast material and paired with myocardial delayed enhancement imaging. Reference tests for ischemia included stress cardiac magnetic resonance imaging, stress echocardiography, single-photon emission computed tomography, or invasive coronary angiography. Diagnostic performance was evaluated using sensitivity, specificity, accuracy, areas under receiver operating characteristic curve analysis (AUC) as well as Youden index-derived thresholds. Forty-one patients were included. There were 28 men and 13 women with a median age of 62 years (Q1, 57; Q3, 70; range: 18-85 years). Of these, 35 patients (85 %) had obstructive coronary artery disease (CAD) on CCTA. PCCT-MPI identified myocardial hypoperfusion in 18 patients (44 %) with a median dose-length product of 97 mGy.cm (Q1, 76.8; Q3, 155.8). Visual assessment yielded 100 % sensitivity (95 % confidence interval [CI]: 81-100 %) and 96 % specificity (95 % CI: 78-100 %), with an AUC of 0.98 (95 % CI: 0.93-1.00) for the diagnosis of ischemic and infarcted myocardium. An optimal defect-to-remote iodine ratio cutoff of 0.79 showed 98 % accuracy (95 % CI: 87-100 %) and an AUC of 0.99 (95 % CI: 0.98-1.00 %). Integration of PCCT-MPI with CCTA could have obviated additional functional testing or invasive angiography in up to 50 % of patients with obstructive CAD. Stress static PCCT-MPI is feasible and demonstrates excellent diagnostic accuracy for detecting myocardial ischemia. Defect-to-remote iodine ratio from spectral imaging further enhances performance, establishing PCCT as a comprehensive imaging modality that unifies anatomic and functional coronary assessment at a reasonable radiation dose, within a single examination.